Presage Biosciences Secures $1,566,295 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=47fcd65a-43e3-4826-954a-9f57bf3ce58b&Preview=1 - Date
8/4/2011 - Company Name
Presage Biosciences - Mailing Address
530 Fairview Avenue North Seattle, WA 98109 - Company Description
Presage Biosciences was founded in November, 2008 based on technology invented in the laboratory of Dr. James Olson, a pediatric oncologist focused on brain tumors. Frustrated by a lack of tools to identify pre-existing resistance to oncology drugs in his patients, Dr. Olson’s team developed a strategy to assess tumor responses to drug treatments empirically, before subjecting patients to a treatment cycle, frequently with side effects. Presage is using Dr. Olson’s invention to improve the lives of cancer patients though drug development applications. - Website
http://www.presagebio.com - Transaction Type
Venture Equity - Transaction Amount
$1,566,295 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
